Oncogramme
Commercial- Indications
- Metastatic colorectal cancer
Company intelligence / Profile preview
Oncomedics
Limoges, Nouvelle-Aquitaine, Franceoncomedics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Oncomedics has developed the Oncogramme, a theranostic technology for personalized cancer care. The company collects human cancer tumors from patients to obtain cancer primary culture as models for cancer research, drug screening, biomarker validation, and individualized diagnostics[1][2][4].
- Therapeutic areas
- Oncology
- Industry
- Molecular Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Beyond the preview
Go deeper on Oncomedics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oncomedics.